Please provide your email address to receive an email when new articles are posted on . Men prescribed long-acting testosterone undecanoate injections had a higher adherence to therapy at 1 year ...
18F-fluorocholine positron emission tomography/computed tomography for early outcome prediction in metastatic castration-resistant prostate cancer patients treated with enzalutamide: A ...
SAN DIEGO -- Long-term testosterone therapy was associated with sustained reductions in weight for men with hypogonadism and class III obesity, a researcher reported. In registry data on 76 patients, ...
Association of polymorphism in YB-1 regulating androgen receptor V7 expression with efficacy of androgen-deprivation therapy in metastatic prostate cancer. This is an ASCO Meeting Abstract from the ...
ORLANDO — After almost a decade of testosterone injections every 3 months, 22% of men with type 2 diabetes and hypogonadism had diabetes remission, in unexpected findings from a small registry study ...
WASHINGTON--An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results